The Patent Finder

Terms ending in 2042

Avedro, Inc.

Every in-force patent on Avedro, Inc.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,016,794Photoactivation Systems and Methods for Corneal Cross-Linking Treatments
In force
 · High confidence
Avedro, Inc.In forceHigh confidence
US 12,344,598Bis(DIAZIRINE) Derivatives as Photo-Crosslinker for Treating Corneal Ectatic Disorders
In force
 · High confidence
Avedro, Inc.In forceHigh confidence
US 12,673,925Compounds and Compositions for Eye Treatments
In force
 · High confidence
Avedro, Inc.In forceHigh confidence
US 11,864,990Bioresorbable Corneal Implants
In force
 · High confidence
Avedro, Inc.In forceHigh confidence
US 12,293,513Systems and Methods for Generating Patient-Specific Corneal Cross-Linking Treatment Patterns
In force
 · High confidence
Avedro, Inc.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited